AFBI stock news
This page provides real-time market news, earnings updates, and company announcements related to Affinity Bancshares, Inc. (AFBI).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 09:42 EST
Akamai Launches AI Grid Intelligent Orchestration for Distributed Inference Across 4,400 Edge Locations
Finviz2026-03-16 20:33:54
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
Finviz2026-03-18 10:58:03
Super League Signs Definitive Agreement to Acquire Misfits Ads Division, Expanding Revenue and Accelerating Path to Positive Adjusted EBITDA
Finviz2026-03-18 12:03:49
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
Finviz2026-03-24 01:42:50
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-24 11:03:57
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
Finviz2026-03-24 12:03:48
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-24 20:12:10
Amazon Confirms Acquisition of Humanoid Robot Startup Fauna Robotics, Enters Consumer Humanoid Robot Market; Sprout Priced at $50,000
今日美股网2026-03-25 00:36:34
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Finviz2026-03-25 12:03:58
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
Finviz2026-03-26 11:03:09
Amaze Holdings Announces Creator Commerce Media Platform, Designed to Unlock Data-Driven Revenue Streams
Finviz2026-03-26 12:31:08
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Finviz2026-03-26 12:31:08
First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
Finviz2026-03-27 13:03:56
Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
Finviz2026-03-27 13:03:55
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Finviz2026-03-28 14:12:37
Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
Finviz2026-03-30 11:03:47
Fidelity Bancshares and its subsidiary Fidelity Bank have officially announced that they have reached a definitive merger agreement regarding the acquisition of Affinity Bancshares, Inc. and its subsidiary Affinity Bank.
老虎证券2026-03-30 21:31:57
After Fidelity Bank announced it will acquire Affinity Bancshares, Inc. for $23 per share in cash, the company's stock surged 13.2% in pre-market trading.
老虎证券2026-03-31 08:44:04
TalentAlly, a Subsidiary of Professional Diversity Network, Inc., Launches Next-Generation Career Fair Hiring Platform Powered by ByteCompute.ai
Finviz2026-04-06 13:03:54
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
Finviz2026-04-07 11:03:42
Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA (bevacizumab-vikg) Accepted by FDA
Finviz2026-04-07 12:54:54
Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
Finviz2026-04-08 11:03:44
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
Finviz2026-03-24 01:42:50
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-24 11:03:57
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
Finviz2026-03-24 12:03:48
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-24 20:12:10
Amazon Confirms Acquisition of Humanoid Robot Startup Fauna Robotics, Enters Consumer Humanoid Robot Market; Sprout Priced at $50,000
今日美股网2026-03-25 00:36:34
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Finviz2026-03-25 12:03:58
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
Finviz2026-03-26 11:03:09
Amaze Holdings Announces Creator Commerce Media Platform, Designed to Unlock Data-Driven Revenue Streams
Finviz2026-03-26 12:31:08
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Finviz2026-03-26 12:31:08
First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
Finviz2026-03-27 13:03:56
Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
Finviz2026-03-27 13:03:55
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Finviz2026-03-28 14:12:37
Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
Finviz2026-03-30 11:03:47
Fidelity Bancshares and its subsidiary Fidelity Bank have officially announced that they have reached a definitive merger agreement regarding the acquisition of Affinity Bancshares, Inc. and its subsidiary Affinity Bank.
老虎证券2026-03-30 21:31:57
After Fidelity Bank announced it will acquire Affinity Bancshares, Inc. for $23 per share in cash, the company's stock surged 13.2% in pre-market trading.
老虎证券2026-03-31 08:44:04
TalentAlly, a Subsidiary of Professional Diversity Network, Inc., Launches Next-Generation Career Fair Hiring Platform Powered by ByteCompute.ai
Finviz2026-04-06 13:03:54
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
Finviz2026-04-07 11:03:42
Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA (bevacizumab-vikg) Accepted by FDA
Finviz2026-04-07 12:54:54
Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
Finviz2026-04-08 11:03:44
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
AFBI stock chart
AFBI stock detailsAFBI stock price change
On the last trading day, AFBI stock closed at 22.35 USD, with a price change of 0.00% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more